Investors must purchase Zydus Lifesciences shares by Wednesday, May 27, to be eligible for the Rs 1,100 crore buyback, as the record date is May 29. The company approved buying back up to 95.65 lakh shares at Rs 1,150 each, a 7% premium. This follows strong Q4 results and a dividend recommendation.
South Korea’s Kospi tanks 8% despite US-Iran war optimism. Here are 4 reasons why
The benchmark Kospi plunged 551 points, or 8.1%, to 6,2505. The steep decline triggered “sidecar” trading curbs on both the Kospi and the junior Kosdaq